MA103Remark Code (RARC)Active
MA103 Remark Code - Hemophilia Add On Explained
The MA103 remark code indicates that the claim includes a Hemophilia Add On. This code serves as a supplemental explanation to adjustments made under the accompanying reason code, clarifying that the services or items billed relate specifically to the treatment of hemophilia.
How It Relates to the Denial
The MA103 remark code typically accompanies adjustment reason codes related to claims for hemophilia treatments. It clarifies that the adjustment reflects the application of an add-on specific to hemophilia care, providing additional context for the billed services.
Common Scenarios
1A provider submitted a claim for a hemophilia treatment that included specific factor replacement therapy. The remittance shows an adjustment for the treatment amount.
→ The MA103 remark code indicates that the adjustment made is due to the inclusion of a Hemophilia Add On, which applies to the treatment billed.
2A facility billed for a hemophilia-related procedure and received a remittance with an adjustment. The accompanying reason code indicated a reduction in payment.
→ The presence of the MA103 remark code clarifies that the payment reduction is due to the application of a Hemophilia Add On related to the services provided.
3A claim for hemophilia management services was submitted, and the remittance included a reason code for a payment adjustment along with the MA103 remark code.
→ This remark code signifies that the adjustment is associated with the specific hemophilia add-on, providing important context for the payment modification.
What to Do
- Review the adjustment reason code accompanying the MA103 remark for specifics on the payment reduction.
- Ensure that the claim documentation accurately reflects the hemophilia services billed and any relevant add-ons.
- If applicable, confirm that the add-on was appropriately applied per the patient's treatment plan.
What to Check
- The claim details to confirm the services billed are related to hemophilia treatment.
- The payer's policy on hemophilia add-ons to ensure compliance with billing guidelines.
- Any notes or documentation related to the hemophilia add-on to support the billing.